PCSK9 and familial hypercholesterolemia: Carreras et al. showed that targeted editing of PCSK9 in the humanized mouse model induced liver-specific expression of human PCSK9 and decreased both protein and plasma total cholesterol (TC) levels resulting in a human-like hypercholesterolemia phenotype [206].